Senator Clinton
Introduces Bill to Help Detect and Prevent Disorders in Infants
Bill inspired by
Hunter Kelly, son of former Buffalo Bills Quarterback Jim Kelly, and his
battle with Krabbe's Disease
Washington, DC - Senator Hillary Rodham Clinton today announced
introduction of bipartisan legislation with Senator George Allen (R-VA)
inspired by the story of Hunter Kelly, the son of Jim and Jill Kelly, and
his battle with Krabbe's disease. The Screening for Health of Infants and
Newborns or SHINE Act would help states increase their newborn screening
capabilities so that all babies have the opportunity for early diagnosis
and lifesaving treatment.
Last week, Senator Clinton also secured $500,000 for the Hunter's Hope
Foundation in the Fiscal Year 2007 Labor, Health and Human Services, and
Education Appropriations Bill.
"Hunter Kelly was a remarkable child, who bravely battled a fatal, nervous
system disease that wasn't caught by infant screening. His parents, Jim
and Jill Kelly, have been tireless advocates for improving newborn
screening to help spare other families from the struggle they experienced
and to help find a cure for disorders that take the lives of children like
Hunter," Senator Clinton said. "This bill is a tribute to Hunter and to
all those children and their families who have faced this kind of struggle
and pain."
Each year four million infants born in the United States are screened
shortly after birth to detect a variety of diseases. In New York, 11
million screening tests are done on the quarter of a million babies born
in the state each year. Currently, with some federal guidance, each state
determines which disorders newborns are tested for and in some states,
it's as few as seven. In New York, newborn screening advocates like the
Kelly family through Hunter's Hope Foundation in Buffalo and Jill Fisch
through her Save Babies Through Screening Foundation in Scarsdale, have
helped expand New York's newborn screening capacity from 11 to 44
conditions.
"Although most of the disorders that are screened for are rare, some may
be life threatening or impede mental and physical development if left
untreated. However, early detection by newborn screening can often lessen
the serious side effects of these diseases or completely prevent them if
medical treatment is started early. The SHINE Act will expand use of
newborn screening so that all babies have the opportunity for early
diagnosis and lifesaving treatment," Senator Clinton said.
The Screening for Health of Infants and Newborns or "SHINE" Act will build
on New York's work by helping states increase their newborn screening
capabilities. In some states this will mean increasing the number of
newborn screening tests, and in states like New York, this will mean
developing new tests for diseases that are not currently tested for.
As with the variability across states in the number and types of
screenings, there is also little consistency with regard to the
interpretation of test results, and how this information is reported and
tracked. The SHINE Act will ensure that all babies are screened using the
same standards so that their diseases are identified quickly and correctly
so any necessary treatment can begin as soon as possible.
The Clinton-Allen legislation will make sure that current information on
newborn screening is available and accessible to health providers and
parents through an internet clearinghouse. This site will be interactive
so that parents can ask questions and receive answers regarding newborn
screening.
"Parents can spend years going to doctors trying to get a diagnosis and
treatment for a sick child. They need to be able to access information
about the benefits and potential risks of the tests and treatments
involved in newborn screening, as well as information about the disorders
themselves in order to best care for their child," Senator Clinton said.
The SHINE Act is supported by:
* Save Babies Through Screening Foundation * March of Dimes * Hunter's
Hope Foundation * Blythedale Children's Hospital
The $500,000 that Senator Clinton secured for the Hunter's Hope Foundation
will help establish the technology infrastructure of the Hunter James
Kelly Research Institute inside the University at Buffalo's Center for
Excellence in Bioinformatics and Life Sciences. This Institute will
coordinate research initiatives into finding a cure for Krabbe's disease
and related genetic disorders. One in 100,000 live births in the United
States are afflicted with Krabbe's Disease. Approximately 2 million people
(or one out of 125) in the United States are carriers of the genetic
deficiency that causes Krabbe's Disease.